Find the market shift before it becomes the obvious trade.
Inflecta connects signals across markets, companies, technology, policy, people, and world events to uncover under-recognized investment stories, then shows the evidence, the risks, and what happens next.
They analyze a ticker you searched for, or summarize news everyone has already seen. By the time a story is on the screen, it is usually the consensus.
It begins with a forming constraint or a cross-market pattern and works toward investable exposure: which companies may benefit, why, what could invalidate the thesis, and whether the market has already caught on.
Structure deduplicated source content into events: actor, action, magnitude, direction, status, provenance.
Link weak signals across companies, industries, policy, technology, people, and geography that no single article states.
Seven analyst roles reason over each cluster, including a skeptic and a crowding analyst, before anything is written.
Score evidence, investability, novelty, and crowding; publish only what survives the gate, with uncertainty exposed.
Measure what happened at 30, 60, 90, and 180 days, and keep the misses visible.
Original dates and calls stay on the record, including the ones that did not work. A recommendation without an outcome is an opinion.
A compact daily briefing on the theses you follow: new opportunities, strengthening or weakening calls, new catalysts, and outcome checkpoints. If nothing material changed, it says so.
- 1 Intelligence Pack, 5 Themes, 10 companies
- Selected opportunities, basic weekly briefing
- 5 grounded Ask Inflecta questions per month
- Paper portfolio up to 5 positions
- 5 Packs, 25 Themes, 50-company watchlist
- Every published thesis, full evidence and contrarian theses
- Daily personalized briefing, unlimited material-change alerts
- 50 Ask Inflecta questions and 2 deep-research runs per month
- Paper portfolio up to 25 positions
Every published thesis is reviewed before it goes out. Facts are cited to their source; inferences are labeled as inferences; when the evidence is thin, confidence drops and the thesis says so.
No. Inflecta is impersonal investment research. It is not personalized advice, not an offer, and never a recommendation to buy or sell any security.
Theses are built from continuously ingested market signals and refreshed as evidence moves. Market prices are delayed or end of day.
Packs are broad coverage areas; Themes are focused topics you follow. Your selections drive personalization and alerts. Every published thesis stays browseable.
You are notified only on material change: a new thesis, a stage transition, a confidence shift, a new catalyst, contradicting evidence, or an outcome. Never every headline.
A simulation. You record hypothetical positions tied to a thesis and watch how the call and the thesis evolve. No brokerage, no execution.
Yes. Cancel from your account and you keep access until the end of the billing period, then move to Free Preview.
See the shift while it is still forming.
Inflecta provides impersonal investment research, not personalized advice, and nothing here is an offer or recommendation to buy or sell any security.